India, Oct. 22 -- Indian shares may open largely unchanged on Friday as investors look for signs of progress in U.S. stimulus talks and await earnings from prominent companies including Nestle India, Tech Mahindra and Yes Bank.
There is some good news on the Covid-19 front, with Bharat Biotech receiving permission to start the Phase III trials of Covaxin, India's indigenous Covid-19 vaccine candidate.
Benchmark indexes Sensex and the Nifty fell modestly on Thursday to snap a four-day winning streak, while the rupee rose by 4 paise to close at 73.54 against the U.S. dollar on sustained foreign fund inflows.
Asian markets are trading mixed this morning as commentators share their thoughts on the final presidential debate involving United S...